bpc-157 human studies dosage safety Protocol: Injection Guide Preclinical safety evaluation of body
Description
Because MOTS-c involves only 4 injections per cycle, rotate to a different quadrant of the abdomen with each dose to minimize localized tissue irritation
doi:10.1111/jdv.12176
A normal level is 400 pg/mL or higher
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease
ClinicalTrials.gov [online], (2014)
